Michael Fraser

22.9k citations
47 papers · 2.3k indexed · h-index 24

Michael Fraser

46 papers receiving 2.2k citations

Peers

Michael Fraser
Comparison fields: 5 of 118
  • Cancer Research 479
  • Oncology 562
  • Molecular Biology 1.4k
  • Pulmonary and Respiratory Medicine 561
  • Urology 106
Replace Yuzo Furuya with:
Yuzo Furuya Japan
Jacek Pinski United States
Marja T. Nevalainen United States
Marcus V. Cronauer Germany
Bora Gürel United States
Eddie Fridman Israel
Ann M. McNulty United States
Colby L. Eaton United Kingdom
Kenji Tamura Japan
Rakesh Singal United States
Michael Fraser relative to Yuzo Furuya Japan Yuzo Furuya's profile →
Citations per field
00.5×10.3×
Yuzo Furuya · 1×
Citations per year

Countries citing papers authored by Michael Fraser

Since Specialization
Citations

This map shows the geographic impact of Michael Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fraser more than expected).

Fields of papers citing papers by Michael Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fraser. The network helps show where Michael Fraser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Fraser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Fraser Line = papers co-authored together Michael Fraser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202321
2 202111
3 20212
4 202062
5 202011
6 201922
7 20196
8 201939
9 201950
10 201832
11 20183
12 2017117
13 2016105
14 201413
15 2011106
16 201196
17 200874
18 200862
19 2007145
20 200145

About Michael Fraser

Michael Fraser is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 47 papers that have together received 2.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Cell death mechanisms and regulation (8 papers), Cancer Genomics and Diagnostics (7 papers), Cancer-related Molecular Pathways (7 papers), Cancer-related gene regulation (4 papers), Molecular Biology Techniques and Applications (4 papers) and Genital Health and Disease (4 papers). The work is most often cited by research in Cancer Research (479 citations), Oncology (562 citations) and Molecular Biology (1.4k citations). Michael Fraser has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Benjamin K. Tsang, Robert G. Bristow, Xiaojuan Yan, Xiaokui Yang, Theodorus van der Kwast, Brendan M. Leung, Tao Bai, Han C. Dan, Jin Q. Cheng and Ute M. Moll. Their work appears in journals such as BMC Bioinformatics, Clinical Cancer Research, Nature Communications, European Urology Focus and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026